Mutual of America Capital Management LLC Has $5.77 Million Stock Holdings in Kenvue Inc. (NYSE:KVUE)

Mutual of America Capital Management LLC lifted its position in Kenvue Inc. (NYSE:KVUE) by 40.4% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 317,504 shares of the company’s stock after buying an additional 91,398 shares during the quarter. Mutual of America Capital Management LLC’s holdings in Kenvue were worth $5,772,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also bought and sold shares of KVUE. Manchester Capital Management LLC boosted its holdings in Kenvue by 80.8% during the first quarter. Manchester Capital Management LLC now owns 1,186 shares of the company’s stock valued at $25,000 after acquiring an additional 530 shares during the period. Poehling Capital Management INC. increased its stake in shares of Kenvue by 0.5% in the second quarter. Poehling Capital Management INC. now owns 104,934 shares of the company’s stock worth $1,908,000 after purchasing an additional 547 shares during the period. Tradition Wealth Management LLC lifted its position in shares of Kenvue by 2.8% during the 4th quarter. Tradition Wealth Management LLC now owns 21,278 shares of the company’s stock worth $458,000 after purchasing an additional 575 shares during the last quarter. MV Capital Management Inc. boosted its stake in Kenvue by 71.2% during the 1st quarter. MV Capital Management Inc. now owns 1,544 shares of the company’s stock valued at $33,000 after purchasing an additional 642 shares during the period. Finally, Cove Private Wealth LLC grew its holdings in Kenvue by 1.6% in the 2nd quarter. Cove Private Wealth LLC now owns 44,539 shares of the company’s stock valued at $810,000 after buying an additional 700 shares during the last quarter. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on KVUE. UBS Group upped their price target on Kenvue from $20.00 to $22.00 and gave the stock a “neutral” rating in a report on Wednesday, August 7th. Citigroup reduced their price target on shares of Kenvue from $21.00 to $20.00 and set a “neutral” rating for the company in a report on Wednesday, July 10th. Royal Bank of Canada restated an “outperform” rating and set a $24.00 price objective on shares of Kenvue in a report on Wednesday, August 7th. JPMorgan Chase & Co. increased their target price on shares of Kenvue from $22.00 to $24.00 and gave the company an “overweight” rating in a research note on Wednesday, August 7th. Finally, Deutsche Bank Aktiengesellschaft boosted their price target on Kenvue from $23.00 to $24.00 and gave the company a “buy” rating in a research note on Wednesday, August 7th. One analyst has rated the stock with a sell rating, six have assigned a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $21.44.

Kenvue Price Performance

Kenvue stock opened at $23.02 on Friday. The business has a 50 day simple moving average of $20.92 and a 200 day simple moving average of $19.96. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.99 and a quick ratio of 0.68. The company has a market capitalization of $44.08 billion, a PE ratio of 29.51, a price-to-earnings-growth ratio of 2.92 and a beta of 1.40. Kenvue Inc. has a one year low of $17.67 and a one year high of $23.55.

Kenvue (NYSE:KVUE) last issued its quarterly earnings data on Tuesday, August 6th. The company reported $0.32 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.28 by $0.04. Kenvue had a return on equity of 21.80% and a net margin of 7.23%. The company had revenue of $4 billion during the quarter, compared to analysts’ expectations of $3.93 billion. During the same period last year, the business earned $0.32 earnings per share. The business’s revenue was down .3% on a year-over-year basis. On average, sell-side analysts forecast that Kenvue Inc. will post 1.08 EPS for the current fiscal year.

Kenvue Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, August 28th. Stockholders of record on Wednesday, August 14th were issued a dividend of $0.205 per share. This is a positive change from Kenvue’s previous quarterly dividend of $0.20. The ex-dividend date of this dividend was Wednesday, August 14th. This represents a $0.82 annualized dividend and a dividend yield of 3.56%. Kenvue’s dividend payout ratio (DPR) is presently 105.13%.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.